Tenet Healthcare (NYSE:THC) Director Tammy Romo Sells 2,500 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 2,500 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00. Following the completion of the transaction, the director owned 28,284 shares in the company, valued at $7,377,315.72. This trade represents a 8.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Tammy Romo also recently made the following trade(s):

• On Thursday, August 6th, Tammy Romo sold 4,922 shares of Tenet Healthcare stock. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30.

Tenet Healthcare Stock Performance

Shares of NYSE:THC traded down $1.80 on Monday, reaching $260.33. 889,058 shares of the company’s stock were exchanged, compared to its average volume of 1,475,405. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $265.32. The company has a fifty day moving average of $202.01 and a 200-day moving average of $201.90. The company has a market capitalization of $20.96 billion, a price-to-earnings ratio of 10.04, a PEG ratio of 1.00 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

THC has been the topic of a number of analyst reports. TD Cowen increased their price objective on shares of Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Truist Financial increased their price target on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a research report on Tuesday, July 28th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, August 3rd. Finally, UBS Group boosted their price target on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $272.25.

Institutional Trading of Tenet Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. Triumph Capital Management bought a new position in shares of Tenet Healthcare in the 3rd quarter valued at $25,000. Activest Wealth Management acquired a new position in Tenet Healthcare in the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new position in Tenet Healthcare in the fourth quarter valued at about $29,000. Meeder Asset Management Inc. boosted its stake in shares of Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after purchasing an additional 114 shares in the last quarter. Finally, Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare in the second quarter valued at approximately $37,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.